Ocugen Announces $22.5 Million Stock Offering Amidst Financial Challenges

Ocugen (OCGN) is raising $22.5 million through a stock offering, which may impact its stock price. The biotech firm plans to use the funds for general corporate needs. Ocugen's financial metrics reveal significant challenges, including negative margins, a high debt-to-equity ratio, and a poor financial health rating due to high leverage. The company operates in the biotech sector, focusing on gene and cell therapies.